NEW YORK (GenomeWeb) – The National Institute of Health will award up to $3.4 million next year to fund genomics research programs and projects aimed at better understanding how two complex human genomic regions are involved in a range of immune system diseases.

The grants will support research programs focused on the HLA (human leukocyte antigen) and the KIR (natural killer cell immunoglobin-like receptor) genomic regions, which are involved in human susceptibility and resistance to immune-related diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.